These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23040900)

  • 1. The neural effects of psychotropic medications in children and adolescents.
    Singh MK; Chang KD
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):753-71. PubMed ID: 23040900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using neuroimaging to evaluate and guide pharmacological and psychotherapeutic treatments for mood disorders in children.
    Singh MK; Garrett AS; Chang KD
    CNS Spectr; 2015 Aug; 20(4):359-68. PubMed ID: 25659836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication effects in neuroimaging studies of bipolar disorder.
    Phillips ML; Travis MJ; Fagiolini A; Kupfer DJ
    Am J Psychiatry; 2008 Mar; 165(3):313-20. PubMed ID: 18245175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.
    Pullen SJ; Wall CA; Angstman ER; Munitz GE; Kotagal S
    J Clin Sleep Med; 2011 Dec; 7(6):587-96. PubMed ID: 22171196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic drug use among preschool children in the Medicaid program from 36 states.
    Garfield LD; Brown DS; Allaire BT; Ross RE; Nicol GE; Raghavan R
    Am J Public Health; 2015 Mar; 105(3):524-9. PubMed ID: 25602884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
    Radigan M; Lannon P; Roohan P; Gesten F
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic drug action.
    Klein DF
    Am J Psychiatry; 1997 Mar; 154(3):440-1. PubMed ID: 9072914
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges and Promises of Pediatric Psychopharmacology.
    Giles LL; Martini DR
    Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
    Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives in psychopharmacological neuroimaging.
    Fusar-Poli P
    Curr Pharm Des; 2009; 15(22):2533-4. PubMed ID: 19689325
    [No Abstract]   [Full Text] [Related]  

  • 14. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
    Comer JS; Olfson M; Mojtabai R
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Lin HY; Gau SS
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv094. PubMed ID: 26377368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for paediatric registries to assess long-term brain effects of psychotropic medications: The case of bipolar disorder.
    Bonati M
    Eur Neuropsychopharmacol; 2019 Jul; 29(7):904. PubMed ID: 31213400
    [No Abstract]   [Full Text] [Related]  

  • 17. Postnatal brain development and psychotropic drugs. Effects on animals and animal models of depression and attention-deficit/hyperactivity disorder.
    Bock N; Gerlach M; Rothenberger A
    Curr Pharm Des; 2010; 16(22):2474-83. PubMed ID: 20513226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic drug treatment in anorexia nervosa. Search for differences in efficacy/tolerability between adolescent and mixed-age population.
    Balestrieri M; Oriani MG; Simoncini A; Bellantuono C
    Eur Eat Disord Rev; 2013 Sep; 21(5):361-73. PubMed ID: 23733453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic Medication Adherence in Children and Adolescents.
    Verma S; Agrawal R
    South Med J; 2021 Jul; 114(7):388-394. PubMed ID: 34215889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.